The purpose of this early feasibility study is to assess the safety and function of the Sierra Ligation System in accessing and closing off the left atrial appendage (LAA) using a minimally invasive epicardial access approach in patients with non-valvular atrial fibrillation and at risk for stroke.
If you are interested in learning more about this study, please refer to the clinicaltrials.gov website: LASSO-AF
ClinicalTrials.gov Identifier: NCT02583178
CAUTION: INVESTIGATIONAL DEVICE.
The LASSO-AF study will be performed under a U.S. Food and Drug Administration (FDA) Investigational Device Exemption and a Health Canada Investigational Testing Authorization.